Nasdaq Rvnc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq rvnc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rvnc Today - Breaking & Trending Today

Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives $15.56 Average PT from Analysts

Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month […] ....

United States , Piper Sandler , Money Concepts Capital Corp , Goldman Sachs Group , Comerica Bank , Needham Company , Tower Group , Assetmark Inc , Revance Therapeutics Inc , Advisor Group Holdings Inc , Revance Therapeutics , Get Free Report , Marketbeat Ratings , Concepts Capital Corp , Advisor Group Holdings , Group Holdings , Get Free , Revance Therapeutics Daily , Nasdaq Rvnc ,

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Purchased by Innovis Asset Management LLC

Innovis Asset Management LLC lifted its stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 266.1% in the third quarter, HoldingsChannel reports. The firm owned 38,501 shares of the biopharmaceutical company’s stock after purchasing an additional 27,984 shares during the period. Innovis Asset Management LLC’s holdings in Revance Therapeutics were worth $442,000 at the […] ....

United States , Piper Sandler , Goldman Sachs Group , Russell Investments Group Ltd , Innovis Asset Management , Principal Financial Group Inc , International Biotechnology Trust , Revance Therapeutics Company Profile , Needham Company , Revance Therapeutics Inc , Rice Hall James Associates , Revance Therapeutics , Free Report , Asset Management , Financial Group , Biotechnology Trust , Investments Group , Rice Hall James , Hall James , Get Free Report , Visit Holdingschannel , Revance Therapeutics Daily , Nasdaq Rvnc , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Revance Therapeutics (NASDAQ:RVNC) Stock Price Up 12.5%

Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) shares shot up 12.5% during mid-day trading on Tuesday . The company traded as high as $5.81 and last traded at $5.74. 615,845 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 1,640,345 shares. The stock had previously closed at […] ....

United States , Piper Sandler , Hermes Inc , Victory Capital Management Inc , Goldman Sachs Group , Jennison Associates , Revance Therapeutics Company Profile , Sargent Investment Group , Revance Therapeutics Inc , Revance Therapeutics , Get Free Report , Capital Management , Investment Group , Federated Hermes , Revance Therapeutics Daily , Nasdaq Rvnc ,

Rice Hall James & Associates LLC Increases Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC)

Rice Hall James & Associates LLC lifted its position in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 23.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 683,937 shares of the biopharmaceutical company’s stock after buying an additional […] ....

United States , Piper Sandler , Morgan Stanley , Exchange Commission , Baldwin Brothers , Money Concepts Capital Corp , Revance Therapeutics Inc , Goldman Sachs Group , Rice Hall James Associates , Assetmark Inc , Tower Group , Advisor Group Holdings Inc , Rice Hall James , Revance Therapeutics , Free Report , Hall James , Concepts Capital Corp , Group Holdings , Therapeutics Stock Down , Get Free Report , Visit Holdingschannel , Revance Therapeutics Daily , Nasdaq Rvnc , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Short Interest in Revance Therapeutics, Inc. (NASDAQ:RVNC) Grows By 16.0%

Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 14,390,000 shares, a growth of 16.0% from the December 15th total of 12,400,000 shares. Based on an average trading volume of 1,720,000 shares, the short-interest ratio […] ....

United States , Piper Sandler , Revance Therapeutics Inc , Tower Research Capital , Baird Financial Group Inc , Life Insurance Co , Needham Company , Morgan Stanley , Mirae Asset Global Investments Co , Centaurus Financial Inc , Revance Therapeutics , Get Free Report , Financial Group , Asset Global Investments , Research Capital , Therapeutics Trading Down , Revance Therapeutics Daily , Nasdaq Rvnc ,